Lawrence Fong

Also affiliated with UCSF Helen Diller Family Comprehensive Cancer Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 58 papers. Top paper: “Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer”.

Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer

Cell(2020)10.1016/j.cell.2020.05.017

N/A

5.5DataRank · unranked

749 citations

Serena S. Kwek, Siddharth S. Raju, Tony Li, Elizabeth McCarthy, Eric D. Chow +15 more

Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes

Cell(2023)10.1016/j.cell.2023.02.021

N/A

4.9DataRank · unranked

421 citations

Trine Line Hauge Okholm, Kyle B. Jones, Elizabeth McCarthy, Candace C. Liu, Jacqueline L. Yee +18 more

Transcriptional mediators of treatment resistance in lethal prostate cancer

Nature Medicine(2021)10.1038/s41591-021-01244-6

N/A

4.8DataRank · unranked

196 citations

Michael S. Cuoco, Jett Crowdis, Alice Bosma-Moody, Zhenwei Zhang, Kevin Bi +35 more

Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up

Annals of Oncology(2022)10.1016/j.annonc.2022.11.012

N/A

3.4DataRank · unranked

116 citations

Daniel Castellano, Petros Grivas, David J. Vaughn, Thomas Powles, Jacqueline Vuky +15 more

Evolution of myeloid-mediated immunotherapy resistance in prostate cancer

Nature(2024)10.1038/s41586-024-08290-3

N/A

2.2DataRank · unranked

154 citations

Zenghua Fan, Matthew Clark, Averey Lea, Diamond Luong, Ali Setayesh +12 more

Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002254

N/A

1.6DataRank · unranked

72 citations

Li Zhang, Sumit K. Subudhi, Brandon Chen, Jaqueline Marquez, Eric V Liu +12 more

Circulating monocytes associated with anti-PD-1 resistance in human biliary cancer induce T cell paralysis

Cell Reports(2022)10.1016/j.celrep.2022.111384

N/A

1.1DataRank · unranked

41 citations

Elizabeth McCarthy, Arielle Ilano, Hai Yang, Li Zhang, Kathryn M. Allaire +14 more

Transcriptional mediators of treatment resistance in lethal prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.19.998450

N/A

1.0DataRank · unranked

26 citations

Michael S. Cuoco, Jett Crowdis, Alice Bosma-Moody, Zhenwei Zhang, Kevin Bi +22 more

Single-cell RNA-seq reveals cell type–specific molecular and genetic associations to lupus

Science(2022)10.1126/science.abf1970

N/A

0.939DataRank · unranked

522 citations

M. Grace Gordon, Meena Subramaniam, Min Cheol Kim, George C. Hartoularos, Sasha Targ +25 more

Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas

British Journal of Cancer(2023)10.1038/s41416-023-02298-8

N/A

0.681DataRank · unranked

11 citations

Jennifer A. Chan, Stephanie J. Wang, Rahul Aggarwal, Susan Calabrese, April DeMore +13 more

Dysregulation of CD4+and CD8+resident memory T, myeloid, and stromal cells in steroid-experienced, checkpoint inhibitor colitis

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008628

N/A

0.507DataRank · unranked

15 citations

Yang-Joon Kim, Elvira Mennillo, I Rusu, Jared L. Bain, Arjun A. Rao +17 more

Modulation of myeloid and T cells in vivo by Bruton’s tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-005425

N/A

0.493DataRank · unranked

11 citations

Courtney B. Betts, Li Zhang, Madeline Griffith, Isabelle G. Solman, Brandon Chen +24 more

Updated results of phase II trial using escalating doses of neoadjuvant atezolizumab for cisplatin-ineligible patients with nonmetastatic urothelial cancer (NCT02451423).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e16510

N/A

0.269DataRank · unranked

5 citations

Li Zhang, David Y. Oh, Sima P. Porten, Maxwell V. Meng, Raj S. Pruthi +15 more

In Vivo Measurement of Granzyme Proteolysis from Activated Immune Cells with PET

ACS Central Science(2021)10.1021/acscentsci.1c00529

N/A

0DataRank · unranked

64 citations

Conner Bardine, André Luiz Lourenço, Yung-Hua Wang, Yangjie Huang, Simon J. Cleary +7 more

Non-radioactive and sensitive tracking of neutrophils towards inflammation using antibody functionalized magnetic particle imaging tracers

Nanotheranostics(2021)10.7150/ntno.50721

N/A

0DataRank · unranked

50 citations

K. L. Barry Fung, Xinyi Zhou, Weiwen Cui, Caylin Colson, David Mai +12 more

Multi-Immune Agonist Nanoparticle Therapy Stimulates Type I Interferons to Activate Antigen-Presenting Cells and Induce Antigen-Specific Antitumor Immunity

Molecular Pharmaceutics(2021)10.1021/acs.molpharmaceut.0c00984

N/A

0DataRank · unranked

22 citations

R. Shihman Chang, Colin R. Zamecnik, Miqdad O. Dhariwala, Lawrence Fong, Tejal A. Desai +1 more

Cross-platform comparison of immune-related gene expression to assess intratumor immune responses following cancer immunotherapy

Journal of Immunological Methods(2021)10.1016/j.jim.2021.113041

N/A

0DataRank · unranked

17 citations

Jason Cham, James V. Cooley, Tao He, Katsunobu Hagihara, Hai Yang +6 more

Tumor morphology and location associate with immune cell composition in pleomorphic sarcoma

Cancer Immunology Immunotherapy(2021)10.1007/s00262-021-02935-2

N/A

0DataRank · unranked

12 citations

Evans Shao, Joey Sheridan, Melissa N. Zimel, Soo‐Jin Cho, Andrew Horvai +5 more

Conditional Cancer Immunotherapy as a Safer Way to Step on the Gas

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1328

N/A

0DataRank · unranked

6 citations

Lawrence Fong, Bridget P. Keenan

Immunogenic priming with 177Lu-PSMA-617 plus pembrolizumab in metastatic castration resistant prostate cancer (mCRPC): A phase 1b study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5053

N/A

0DataRank · unranked

32 citations

Srey Luch Sam, Vadim S. Koshkin, Eric J. Small, Felix Y. Feng, Ivan de Kouchkovsky +12 more

Phase II trial of escalating doses of neoadjuvant atezolizumab for patients with non-metastatic urothelial carcinoma ineligible for cisplatin-based neoadjuvant chemotherapy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.442

N/A

0DataRank · unranked

8 citations

Divya Natesan, Li Zhang, David Y. Oh, Sima P. Porten, Maxwell V. Meng +6 more

The impact of prior radiation therapy on outcome in a phase 2 trial combining sipuleucel-T (SipT) and ipilimumab (Ipi) in patients (pts) with metastatic castration resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5045

N/A

0DataRank · unranked

4 citations

Meenal Sinha, Sumit K. Subudhi, Brandon Chen, Jaqueline Marquez, Eric Liu +12 more

Dissecting tumor cell programs through group biology estimation in clinical single-cell transcriptomics

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.22.465130

N/A

0DataRank · unranked

2 citations

Kevin Bi, Breanna M. Titchen, Jingxin Fu, Jake R. Conway, Jett Crowdis +8 more

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-1123

N/A

0DataRank · unranked

67 citations

Shuang G. Zhao, Samuel Levy, Meng Zhang, Yuhong Ning, Raunak Shrestha +58 more

Agonizing over the Stimulatory Immune Checkpoint ICOS

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1520

N/A

0DataRank · unranked

11 citations

Lawrence Fong, Jerry C. Lee

Pembrolizumab (PEM) plus granulocyte macrophage colony stimulating factor (GM-CSF) in advanced biliary cancers (ABC): Final outcomes of a phase 2 trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.444

N/A

0DataRank · unranked

9 citations

Paige M. Bracci, Bridget P. Keenan, Spencer C. Behr, Faaiz Ibrahim, M. Pollak +8 more

Exhausted intratumoral Vδ2− γδ T cells in human kidney cancer retain effector function

Nature Immunology(2023)10.1038/s41590-023-01448-7

N/A

0DataRank · unranked

81 citations

Marcel Arias-Badia, Pranay Dogra, Brandon Chen, Dvir Aran, Hai Yang +11 more

TCR signaling promotes formation of an STS1-Cbl-b complex with pH-sensitive phosphatase activity that suppresses T cell function in acidic environments

Immunity(2023)10.1016/j.immuni.2023.11.010

N/A

0DataRank · unranked

27 citations

Marcel Arias-Badia, Theresa A. Kadlecek, Yee May Lwin, Aahir Srinath, Neel H. Shah +6 more

Early Liver Specialist Consultation is Associated With Faster Biochemical Resolution of Severe Immune Checkpoint Inhibitor–Induced Hepatitis

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.7013

N/A

0DataRank · unranked

11 citations

Danny Wong, Jordan Sack, Alexander S. Vogel, F. Stephen Hodi, Lawrence Fong +4 more

CD4+ T cells help myeloid-mediated killing of immune-evasive tumors

Trends in cancer(2023)10.1016/j.trecan.2023.07.013

N/A

0DataRank · unranked

6 citations

Lawrence Fong, Kaichun Wu

The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapies

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad151

N/A

0DataRank · unranked

6 citations

Andrew G. Sikora, Himangi Marathe, Song Liu, Michael Demetriou, Lawrence Fong +8 more

CD4+ T cells in antitumor immunity

Trends in cancer(2024)10.1016/j.trecan.2024.07.009

N/A

0DataRank · unranked

109 citations

David Y. Oh, Lawrence Fong, Elena Montauti

Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancer

Journal of Clinical Investigation(2024)10.1172/jci180282

N/A

0DataRank · unranked

49 citations

Jessica C. Stark, G. Edward Marti, Zenghua Fan, Aram Lyu, Fernando Jose Garcia Marques +12 more

Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0559

N/A

0DataRank · unranked

46 citations

Fanny Polesso, Julie N. Graff, Jessica E. Hawley, Alexis K. Smith, Arian Lundberg +35 more

CD4+ CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapy

Blood Advances(2024)10.1182/bloodadvances.2023012416

N/A

0DataRank · unranked

44 citations

Zenghua Fan, Kaichun Wu, Elizabeth McCarthy, Axel Hyrenius‐Wittsten, Alec Starzinski +14 more

Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

Cancer Immunology Research(2024)10.1158/2326-6066.cir-22-0306

N/A

0DataRank · unranked

36 citations

Lucia Kwak, Alexander Cheung, Kathryn M. Allaire, Jaqueline Marquez, David D. Yang +21 more

PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-0722

N/A

0DataRank · unranked

12 citations

Li Wang, James R. Byrnes, Lisa L. Kirkemo, Hannah Driks, Cassandra D. Belair +6 more

E-cigarette exposure disrupts antitumor immunity and promotes metastasis

Frontiers in Immunology(2024)10.3389/fimmu.2024.1444020

N/A

0DataRank · unranked

8 citations

Chien-Chun Steven Pai, Peixi Chen, Anthony Chang, Yee May Lwin, Aahir Srinath +4 more

PVRL2 Suppresses Anti-tumor Immunity Through PVRIG- and TIGIT-Independent Pathways

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.01.26.577132

N/A

0DataRank · unranked

0 citations

Li Wang, James R. Byrnes, Lisa L. Kirkemo, Hannah Driks, Cassandra D. Belair +6 more

Tumor cell heterogeneity drives spatial organization of the intratumoral immune response

The Journal of Experimental Medicine(2025)10.1084/jem.20242282

N/A

0DataRank · unranked

18 citations

Lotus Lum, Kenneth H. Hu, Piyush Chaudhary, Savannah Hughes, Cecilia Ledezma-Soto +13 more

CD4+ T cell dysfunction in cancer

The Journal of Experimental Medicine(2025)10.1084/jem.20241417

N/A

0DataRank · unranked

12 citations

Lawrence Fong, Hrishi Venkatesh

Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3693

N/A

0DataRank · unranked

9 citations

Karen A. Autio, Christopher R. Cabanski, Kristopher Wentzel, Julie N. Graff, Terence W. Friedlander +19 more

Identification and regulation of circulating tumor-TCR-matched cytotoxic CD4+ lymphocytes by KLRG1 in bladder cancer

JCI Insight(2025)10.1172/jci.insight.177373

N/A

0DataRank · unranked

4 citations

Hai Yang, Tony Li, Arielle Ilano, Eric D. Chow, Li Zhang +13 more

Dissecting tumor cell programs through group biology estimation in clinical single-cell transcriptomics

Nature Communications(2025)10.1038/s41467-025-57377-6

N/A

0DataRank · unranked

0 citations

Kevin Bi, Breanna M. Titchen, Jingxin Fu, Jake R. Conway, Jett Crowdis +8 more

Expression of Programmed Death-Ligand 1 and Programmed Cell Death-1 Across the Anal Neoplasia Disease Continuum and Association With Survival in Anal Cancer

Modern Pathology(2025)10.1016/j.modpat.2025.100918

N/A

0DataRank · unranked

0 citations

Cynthia Gasper, Ann Lazar, Kathryn M. Allaire, Teresa M. Darragh, Lawrence Fong +2 more

705 Immunosuppressive CD14 + monocytes are enriched in patients with hepatocellular carcinoma and worse liver function (child-pugh B) and are associated with unfavorable immunotherapy outcomes

Regular and Young Investigator Award Abstracts(2025)10.1136/jitc-2025-sitc2025.0705

N/A

0DataRank · unranked

0 citations

Bridget P. Keenan, Bryan Le, Quincy Harris, J.J. Chen, Matthew D. Clark +12 more

TCR Convergence in Individuals Treated With Immune Checkpoint Inhibition for Cancer

Frontiers in Immunology(2020)10.3389/fimmu.2019.02985

N/A

0DataRank · unranked

58 citations

Denise Topacio-Hall, Geoffrey Lowman, Jeffrey M. Conroy, Carl Morrison, David Y. Oh +3 more

Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer

Molecular Therapy(2020)10.1016/j.ymthe.2020.07.017

N/A

0DataRank · unranked

56 citations

Alexander C. Jordan, Evan Tooker, Simon F. Lacey, Renee B. Chang, Yan Li +11 more

Immune Checkpoint Inhibition in Prostate Cancer

Trends in cancer(2020)10.1016/j.trecan.2020.01.003

N/A

0DataRank · unranked

20 citations

Lawrence Fong, Lowell T. Nicholson

Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000796

N/A

0DataRank · unranked

13 citations

Andrew G. Sikora, Catherine M. Bollard, José R. Conejo-García, Carolina Colli Cruz, Shadmehr Demehri +21 more

Long-term Sculpting of the B-cell Repertoire following Cancer Immunotherapy in Patients Treated with Sipuleucel-T

Cancer Immunology Research(2020)10.1158/2326-6066.cir-20-0252

N/A

0DataRank · unranked

23 citations

Harini Kandadi, Hai Yang, Jason Cham, Tao He, David Y. Oh +3 more

Effect of modulation of CD3 binding in a PSMAxCD3 T-cell engaging bispecific antibody on maintenance of efficient tumor cell kill and cytokine release.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e17583

N/A

0DataRank · unranked

1 citations

Kevin Dang, Pranjali Dalvi, Yuping Li, Alexander Cheung, Chiara Rancan +10 more

Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance

UNC Libraries(2020)10.17615/ahxn-k363

N/A

0DataRank · unranked

0 citations

Yafei Hou, Maria L. Mouchess, Kayla J. Fasano, Meng Zhu, Lawrence Fong +4 more

Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox

Immunity(2021)10.1016/j.immuni.2021.11.015

N/A

0DataRank · unranked

449 citations

Lawrence Fong, David Y. Oh

Discovering dominant tumor immune archetypes in a pan-cancer census

Cell(2021)10.1016/j.cell.2021.12.004

N/A

0DataRank · unranked

176 citations

Bushra Samad, Jessica Tsui, Nayvin W. Chew, Peter Yan, Gabriella C. Reeder +75 more

Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002181

N/A

0DataRank · unranked

114 citations

Edbert D Lu, O. Badillo, Shokoufeh Karimi, Eric V Liu, Whitney Tamaki +19 more

Attenuating CD3 affinity in a PSMAxCD3 bispecific antibody enables killing of prostate tumor cells with reduced cytokine release

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002488

N/A

0DataRank · unranked

73 citations

Giulia Castello, Starlynn Clarke, Yuping Li, Aarti Balasubramani, Andrew Boudreau +18 more

IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002903

N/A

0DataRank · unranked

67 citations

Chihiro Morishima, Russell Z. Szmulewitz, Lauren C. Harshman, Leonard J. Appleman, Paul Monk +18 more